Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON32768
NL-OMON32768
Recruiting
Not Applicable

*The use of 18F-fluorodeoxyglucose positron emission tomography and computed tomography imaging for the detection of inflammation in steatotic livers as an indicator of non-alcoholic steatohepatitis* - The FLAME study: FDG detection of inflammation in steatosis

Vrije Universiteit Medisch Centrum0 sites16 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Vrije Universiteit Medisch Centrum
Enrollment
16
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • •\* Men and women \* 18 yrs of age
  • •\* Fasting plasma glucose \*7\.0 mmol/l
  • •\* Liver biopsy in the last 6 months prior to inclusion or existing medical indication indication for liver biopsy
  • •\* Written informed consent

Exclusion Criteria

  • •\* Exclusion criteria for MR (claustrophobia, pacemaker, metal implants, etc)
  • •\* Exclusion criteria for liver biopsy (bleeding tendency, extended bile ducts etc)
  • •\* ALT levels \* 150 IU/ml
  • •\* Creatinine levels \* 120 IU/ml
  • •\* Present excessive alcohol use defined as \> 2 units/day
  • •\* Present abuse of i.v. drugs (including methadon)
  • •\* Infection with HIV or Hepatitis B/C
  • •\* A psychiatric, addictive or any disorder that compromises the subjects ability to understand the study content and to give written informed consent for participation in the study

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Not Applicable
Combined 18F-Fluorodeoxyglucose (FDG) Positron Emission Tomography (PET) and Metomidate Imaging for Adrenal Neoplasia (FAMIAN-Study) - a Diagnostic Studyindeterminate adrenal neoplasiasTherapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Diagnosis [E01]
EUCTR2012-003604-13-DEniversity Hospital Wuerzburg220
Recruiting
Not Applicable
[18F]-Fluorodeoxyglucose Positron Emission Tomography for In Vivo Assessment of Glucose Metabolism in Pheochromoctyoma and Paragangliomaadrenal tumours1002911210014710
NL-OMON38518niversitair Medisch Centrum Sint Radboud25
Completed
Not Applicable
[18F]-Fluorodeoxyglucose Positron Emission Tomography in Lung Tumour Assessment, Research into Characteristicslung cancernon-small cell lung carcinoma1003866610029107
NL-OMON32809niversitair Medisch Centrum Sint Radboud54
Completed
Not Applicable
The usefulness of fluorodeoxyglucose-positron emission tomography as a preoperative diagnostic tool for thymic epithelial tumorsThymic epithelial tumors
JPRN-UMIN000040365Department of Oncology, Immunology and Surgery, Nagoya City University Graduate School of Medical Sciences51
Completed
Not Applicable
The value of F-18-fluorodeoxyglucose Positron Emission Tomography for detection of Metastatic Infectious foci complicating gram-positive bacteraemiaMetastatic infection/ gram-positive bacteraemiaInfections and Infestations
ISRCTN76425553niversity Medical Centre St. Radboud (The Netherlands)115